"Het team van Exact Sciences is er trots op de toegang tot Cologuard Plus uit te breiden via onze samenwerking met Humana, waardoor meer mensen vanuit huis toegang krijgen tot deze revolutionaire, ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Madison, Wis.-based Exact Sciences Corp. agreed to a contract with Louisville, Ky.-based Humana to cover its Cologuard colon cancer screening test as an in-network service.

On Tuesday, Stifel reaffirmed its Buy rating and $67.00 price target for Exact Sciences (NASDAQ: EXAS), following the announcement of a Medicare reimbursement increase for the company's Cologuard ...

Cologuard Plus is a more sensitive version of the original Cologuard that was first approved in 2014. The test is for people 45 and older who are at average risk of colorectal cancer, meaning ...

Colonoscopy is recommended for people over 45, but preparation turns off many. Here's a look at how it compares to stool tests FIT and Cologuard.

Effective Jan. 1, Cologuard will be available to most Humana policyholders without co-payment. The test is now covered by health plans with more than 153 million combined members, according to an ...